RESEARCH

Research News

Check out the latest in pulmonary hypertension research news taking place across the globe and right here in Canada, from progress in understanding the science behind pulmonary hypertension to developments in early diagnosis, treatment, and improving quality of life.

Blood test identified as a good biomarker for idiopathic PAH

5 days ago

Doctors and patients recognize PAH symptom severity differently

Jan 5

Racial and ethnic equity in PAH clinical trials

Dec 22, 2025

Air pollution may worsen PAH

Dec 8, 2025

Kettlebell exercise training was safe and effective for PAH patients

Nov 24, 2025

Prostacyclin analogues protect against age-related macular degeneration

Nov 10, 2025

Inhaled nitric oxide in the first week of life helps the eyes of babies with PPHN

Oct 27, 2025

Economic analysis of virtual vs. centre-based pulmonary rehabilitation

Oct 14, 2025

Pericardial effusion in patients treated with sotatercept

Oct 2, 2025

Distinct blood vessel lining in CTEPH

Sep 15, 2025

Very premature babies with PH who respond to inhaled nitric oxide have better survival

Sep 1, 2025

New PAH-associated genes identified

Aug 29, 2025

Uric acid might cause PAH

Aug 18, 2025

Non-oral therapies burden PAH patients

Aug 4, 2025

Early dual treatment helps late-diagnosed PAH patients catch up

Jul 21, 2025

Good news: treatments have significantly increased five-year survival for CTEPH

Jul 18, 2025

Hymecromone clinical trial is cautiously positive

Jul 7, 2025

Meth-associated PAH care gaps: closing the divide

Jun 23, 2025

IV selexipag can be used as a bridging therapy

Jun 9, 2025

Prostacyclin analogues for CTEPH?

May 26, 2025

Some PAH patients on sotatercept can stop taking prostacyclin analogues

May 12, 2025

Poverty and isolation are associated with worse pulmonary hypertension outcomes

Apr 28, 2025

Some PH patients with interstitial lung disease may benefit from oral PAH drugs

Apr 14, 2025

ZENITH results published: sotatercept is effective for high-risk PAH patients

Apr 8, 2025

Main pulmonary artery diameter predicts risk in PAH patients

Mar 31, 2025

Plain-language summary available for the TORREY seralutinib study

Mar 17, 2025

PAH patients who skip treatment don't do as well as patients who adhere to their treatment plan

Mar 3, 2025

Newly diagnosed PAH patients on triple therapy have fewer hospitalizations vs. double therapy

Feb 18, 2025

HYPERION sotatercept study has positive results, stops early

Feb 10, 2025

Treprostinil benefits PAH patients with cardiovascular issues

Feb 4, 2025

Sotatercept safe and effective across cardiac index groups

Dec 18, 2024

ZENITH study shows sotatercept is effective for PAH patients at high risk of mortality

Nov 26, 2024

Update: Canadian Drug Agency Funding Success for Pulmonary Hypertension Research

Oct 24, 2024

Rural and urban PH patients receive equivalent care

Oct 24, 2024

Sotatercept is now listed on Health Canada's website

May 13, 2024

Dr. Jason Weatherald Discusses the Burden of PAH on the PHaware Podcast

May 5, 2024

The FDA has granted approval for the medication sotatercept

Mar 26, 2024

The evolving landscape of pulmonary arterial hypertension clinical trials

Nov 26, 2022

Medications for the treatment of pulmonary arterial hypertension

Aug 10, 2022

Advances in Pulmonary Hypertension: Quality of Life

Jul 10, 2022

Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications

Jul 8, 2022

Inhaled Seralutinib Shows Promise in 2 PAH Animal Models

Jun 14, 2022

Opsyvni enters pCPA negotiations

Mar 28, 2022

Social Media Participation Among Parents and Caregivers of Children With Pulmonary Hypertension

Mar 15, 2022

Palliative Care and Pulmonary Arterial Hypertension

Mar 15, 2022

BET Protein Inhibition for Pulmonary Arterial Hypertension

Mar 14, 2022